Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Verifiedinfo

Studieenheten Akademiskt Specialistcentrum

Sweden Olivecronas väg 15, 113 61 Stockholm, Sweden

  • 1 trial recruiting
  • Respiratory syncytial virus infection · Lyme disease
  • Adults and children

About Specializations

Studieenheten Akademiskt Specialistcentrum in Stockholm, Sweden specialises in clinical trials of conditions such as Respiratory syncytial virus infection, Lyme disease, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases at Studieenheten Akademiskt Specialistcentrum

This neurology research site in Stockholm is focused on Nervous System Diseases, with clinical studies centered on Amyotrophic Lateral Sclerosis. The trials are aimed at advancing understanding of this serious neurodegenerative condition and evaluating new treatment options for people affected by it.

  • Research into Amyotrophic Lateral Sclerosis and related neurology care
  • Studies exploring new therapies for sporadic and familial ALS

The clinical research at Studieenheten Akademiskt Specialistcentrum is helping assess whether emerging approaches may improve disease management and support future treatment development.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Olivecronas väg 15113 61 StockholmSweden
Open in maps ↗
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified

More sites in StockholmSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Respiratory syncytial virus infection

Recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:Karolinska Institutet

Lyme disease

Not recruiting
Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:Sodium Chloride Solution 0.9%
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).